产品描述
| 溶解性 | ≥9.25 mg/mL in DMSO with gentle warming, <2.37 mg/mL in EtOH, <2.58 mg/mL in H2O |
| 存贮条件 | 储存温度 -20°C |
| 应用 | An antibacterial |
| 产品介绍 | Torezolid (TR-701; tedizolid)是可逆的人MAO-A和MAO-B抑制剂，具有抗革兰氏阳性菌的活性。 |
| 生化机理 |
Torezolid (also known as TR-701 and now tedizolid) is an oxazolidinone drug in phase-II clinical trials for complicated skin and skin-structure infections (cSSSI), including those caused by Methicillin-resistant Staphylococcus aureus (MRSA). From Wikipedia |
| 别名 | TR-700; DA-7157; TR 700; DA 7157;3-[3-氟-4-[6-(2-甲基-2H-四唑-5-基)-3-吡啶基]苯基]-5-(羟基甲基)-2-恶唑烷酮;TR-700; DA-7157; Torezolid; TR 700; DA 7157;3-[3-Fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-5-(hydroxymethyl)-2-oxazolidinone |
